Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Clinical research has demonstrated that AOD-9604 can produce meaningful metabolic effects and body composition improvements, particularly in reducing abdominal and visceral fat deposits
These are important questions to ask, and at Disability Experts, were here to help
Consult a qualified healthcare provider before starting any peptide protocol
When can results be expected in studies
A PlexusDx provider conversation can integrate your genetic context, baseline biomarker results, clinical evidence for GHK-Cu, and your individual hair loss pattern to help determine whether GHK-Cu, nutritional optimization, or another approach may be more appropriate first
Professor Goldsteins research contributions include: Co-discovery and isolation of the thymosin family of peptides in the 1960s First clinical trials of thymosin preparations in immunodeficient children (1974) Characterization of thymosin beta-4s actin-binding and wound healing properties Development of therapeutic applications for tissue repair and regeneration Over 450 published scientific articles and 25+ patents related to thymosins Leadership in translating thymosin research toward clinical development Disclaimer: This spotlight is provided for educational purposes to acknowledge scientific contributions to BPC-157 and TB-500/thymosin beta-4 research
